Sean Cannady
Family Medicine · Spring Hill, TNNPI 1487067963
Payments from drug & device makers
Across 425 payments — averaging $17.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$945
- Pfizer$919
- AstraZeneca$662
- Lilly USA, LLC$580
- Amgen$351
- plus $3K from 37 others
What the payments were for
- Food & beverage$7,425100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,425 in reported general payments places this provider in the 85th percentile of 2,087 family medicine providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 129 | $183,885 |
| MounjaroTirzepatide | 93 | $134,622 |
| OzempicSemaglutide | 56 | $104,854 |
| EliquisApixaban | 54 | $71,752 |
| FarxigaDapagliflozin Propanediol | 44 | $58,014 |
| JanuviaSitagliptin Phosphate | 38 | $42,077 |
| XareltoRivaroxaban | 22 | $36,261 |
| TrulicityDulaglutide | 17 | $26,971 |
| Tresiba Flextouch U-200Insulin Degludec | 16 | $24,326 |
| ProliaDenosumab | 12 | $20,572 |
| Breo ElliptaFluticasone/Vilanterol | 28 | $14,084 |
| MyrbetriqMirabegron | 21 | $13,633 |
| Tresiba Flextouch U-100Insulin Degludec | 16 | $12,562 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $11,475 |
| LinzessLinaclotide | 15 | $7,959 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $133 | $183,885129 claims |
| Lilly USA, LLCMounjaro, Trulicity, Humalog | $580 | $166,334123 claims |
| Novo NordiskOzempic | $945 | $104,85456 claims |
| PfizerEliquis | $919 | $71,75254 claims |
| AstraZenecaFarxiga | $662 | $58,01444 claims |
| MerckJanuvia | $111 | $42,07738 claims |
| Johnson & JohnsonXarelto | $88 | $36,26122 claims |
| AmgenProlia | $351 | $20,57212 claims |
| GSKBreo Ellipta | $294 | $14,08428 claims |
| Astellas Pharma US IncMyrbetriq | $17 | $13,63321 claims |
| AbbVieLinzess, Synthroid | $1,139 | $9,72954 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $16 | $3,612355 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,087 family medicine providers in Tennessee.
Other family medicine in Spring Hill
- Renee DhillonSpring Hill$18K
- Rickey ManningKnoxville$8.1M
- Kymberly MoyerGallatin$5.9M
- Natasha BallardChattanooga$5.7M
- Hina BudhwaniNashville$4.7M
- Paul WakefieldKnoxville$4.3M
- Emily HubbsKingsport$2.8M
- Jerry PunchKnoxville$2.1M
- Bridgette FraneyNashville$2M
- Andrew BrockmyreBristol$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.